Hexsel Dermatology Clinic
14
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
7.1%
1 terminated/withdrawn out of 14 trials
91.7%
+5.2% vs industry average
71%
10 trials in Phase 3/4
82%
9 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
Role: lead
Evaluation of the Efficacy and Onset of Action of a Topical Anesthetic Marker
Role: lead
Quality of Life and Self-esteem After Botox® Injections in Depressed and Non-depressed Patients
Role: lead
Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks
Role: lead
Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses
Role: lead
Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®)
Role: lead
A Fixed Triple Combination Cream for Solar Lentigines Associated to Cryotherapy
Role: lead
Safety and Efficacy of a Metallic Cannula Versus A Standard Needle for Soft Tissue Augmentation of the Nasolabial Folds
Role: lead
Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum
Role: lead
Use Of Three Commercial Preparations Of Injectable Hyaluronic Acid In Hands Rejuvenation
Role: lead
Field of Effects of Two Commercial Preparations of Botulinum Toxin Type A
Role: lead
Comparison of Two Commercial Preparations of Botulinum Toxin Type A
Role: lead
Evaluation Of The Efficacy and Safety Of Tri-ActiveTM In Treatment Of Cellulite
Role: lead
Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring
Role: lead
All 14 trials loaded